共 5 条
[1]
Safety and tolerability of rivastig-mine capsule with memantine in patients with probable Alzheimer’’s dis-ease:a 26-week,open-label,prospective trial〔J〕. Olin JT,Bhatnagar V,Reyes P,et al. Int J Geriatr Psychia-try . 2010
[2]
Recent developments in cholinesterasesinhibitors for Alzheimer’’s disease treatment〔J〕. Musia LA,Bajda M,Malawska B. Current Medicinal Chemistry . 2007
[3]
The identification andcharacterization of excitotoxic nerve-endings in Alzheimer disease〔J〕. Tannenberg RK,Scott HL,Westphalen RI,et al. Curr Alzheimer Res . 2004
[4]
Memantine treatment decreases lev-els of secreted Alzheimer’’s amyloid precursor protein (APP)and amyloidbeta (A beta)peptide in the human neuroblastoma cells〔J〕. Ray B,Banerjee PK,Greig NH,et al. Neuroscience Letters . 2010
[5]
Memantine reduces oxidative damage and enhances long-term recognition memory in aged rats. Pieta Dias,C,Martins de Lima,MN,Presti-Torres,J,Dornelles,A,Garcia,VA,Siciliani Scalco,F,Rewsaat Guimaraes,M,Constantino,L,Budni,P,Dal-Pizzol,F,Schroder,N. Neuroscience . 2007